financetom
Business
financetom
/
Business
/
Nvidia-backed CoreWeave downsizes US IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvidia-backed CoreWeave downsizes US IPO
Mar 27, 2025 8:05 PM

(Reuters) -CoreWeave reduced the size of its U.S. initial public offering and priced its shares below the indicated range, the company said on Thursday, dampening expectations that the listing would boost investor appetite for IPOs.

The Nvidia-backed company is now looking to sell 37.5 million shares, 23.5% less than originally planned, and price them at $40 apiece, well below even the lower end of the indicated range.

CoreWeave will offer 36.6 million of those shares while existing stockholders will sell 910,000 shares.

Nvidia will anchor the CoreWeave IPO at the price with a $250 million order, a person familiar with the matter told Reuters earlier on Thursday.

The sale would raise about $1.5 billion and value CoreWeave at about $23 billion on a fully diluted basis, according to Reuters' calculations.

CoreWeave's roadshow, which began last week, received a weaker-than-expected reception as risk-averse investors in a volatile market weighed concerns over the company's long-term growth, financial risks and capital intensity, according to four sources familiar with the matter.

Among the concerns is CoreWeave's heavy reliance on Microsoft, whose shifting AI datacenter strategy could impact long-term demand for chips known as graphics processing units, or GPUs. While investors appear comfortable with the company's high leverage since it has strong free cash flow, the risk of commitments not being fulfilled remains a worry.

Additionally, CoreWeave's capital-intensive business model raises questions about sustainability, adding to broader market uncertainty.

CoreWeave has been a significant customer for Nvidia, deploying over 250,000 of Nvidia's GPUs by the end of 2024. Investors' lukewarm reception to the CoreWeave IPO could signal reduced confidence in the AI infrastructure market, as the scaling of GPU assets in AI training slows down.

"The business model doesn't appear fundamentally flawed, but this suggests investors are recalibrating AI infrastructure valuations," said Lukas Muehlbauer, research analyst at IPOX.

CoreWeave and some existing investors had initially aimed to sell 49 million shares in the offering priced between $47 and $55 each to raise as much as $2.7 billion. That would have valued the company at up to $32 billion on a fully diluted basis. 

MOUNTING CONCERNS 

CoreWeave's stock market debut has been closely watched as a test of the strength of a recovery in the U.S. IPO market and whether investor enthusiasm for AI newcomers remains strong or has started to wane.

The number of U.S.-listed equity capital markets deals, including both IPOs and block trades of shares, fell to 187 in the first three months of this year, down from 243 during the same period last year, according to Dealogic data through Wednesday. The total value of these transactions also dipped, falling from $74.02 billion to $63.48 billion.

Despite the AI boom, there are growing concerns that data center spending will be uneven, with investments concentrated among a few giants while others struggle to keep pace.

DeepSeek, China's low-cost AI rival, has also emerged as a growing threat, fueling concerns about pressure on data center spending. 

CoreWeave had debt of about $8 billion as of last year. It also leases its 32 data centers and some equipment, instead of owning them, resulting in operating lease liabilities of $2.6 billion.

In its offering filing, the company had said about $1 billion of the IPO proceeds would be used to pay down debt. The company has said it would continue to borrow.

CoreWeave has yet to turn a profit, and IPO investors in the last few years have been wary of backing companies with no history of profitability.

Ahead of its IPO, CoreWeave secured partnerships with major AI players, including Sam Altman's OpenAI. Earlier this month, it signed an $11.9 billion infrastructure deal with the ChatGPT maker.

The cloud services provider, which offers access to data centers and high-powered Nvidia chips for AI workloads, will also issue $350 million in shares to OpenAI through a private placement as part of the offering.

Morgan Stanley, J.P. Morgan and Goldman Sachs are the lead underwriters of the IPO. 

The downsizing was first reported by Semafor on Thursday. 

(Reporting by Echo Wang, Krystal Hu, Milana Vinn in New York, Manya Saini, Niket Nishant, Ateev Bhandari and Surbhi Misra in Bengaluru ; Editing by Sriraj Kalluvila, Leslie Adler and Mrigank Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved